TELA Bio Reports Strong Third Quarter 2021 Revenues
MALVERN, PA — TELA Bio, Inc. (Nasdaq: TELA) reported third quarter 2021 financial results.
Read MoreTELA Bio
TELA Bio, Inc. (Nasdaq: TELA), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.
TELA Bio Announces Publication of 12-Month Results from the BRAVO Study
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced the recent publication of the 12-month analysis from the BRAVO Study in the Journal of Clinical Medicine.
Read More TELA Bio to Participate in Three Upcoming Conferences
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced that the Company will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum, 12th Annual Jefferies London Healthcare …
Read More TELA Bio and Next Science Enter into Exclusive Distribution Agreement
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced it recently entered into a distribution agreement with Next Science, a medical technology company, granting TELA exclusive rights to sell and …
Read More TELA Bio to Announce Third Quarter 2021 Financial Results
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced that the company will report third quarter 2021 financial results on Wednesday, November 10, 2021. TELA Bio’s management will host a …
Read More TELA Bio Appoints Roberto Cuca as Chief Operating Officer and Chief Financial Officer
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced the recent appointment of Roberto Cuca as the Company’s new Chief Operating Officer (COO) and Chief Financial Officer (CFO). As COO …
Read More TELA Bio Announces New Data on Use of OviTex in a Range of Hernia Repair Applications
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced details of the clinical research presented last week at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) meeting in Las …
Read More TELA Bio’s OviTex Reinforced Tissue Matrix to be Featured in Three Presentations at SAGES 2021
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced three upcoming poster presentations on its OviTex Reinforced Tissue Matrix portfolio. Data demonstrating the effectiveness of OviTex in a variety of …
Read More TELA Bio Reports Record Second Quarter 2021 Revenues
MALVERN, PA — TELA Bio, Inc. (Nasdaq: TELA) recently reported second quarter 2021 financial results.
Read More TELA Bio to Participate in Canaccord Genuity’s 41st Annual Growth Conference
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced that the Company will participate in Canaccord Genuity’s 41st Annual Growth Conference.
Read More